JHQPX
Price
$33.64
Change
+$0.01 (+0.03%)
Updated
Aug 7 closing price
Net Assets
21.1B
LONAX
Price
$14.48
Change
-$0.03 (-0.21%)
Updated
Aug 7 closing price
Net Assets
137.81M
Interact to see
Advertisement

JHQPX vs LONAX

Header iconJHQPX vs LONAX Comparison
Open Charts JHQPX vs LONAXBanner chart's image
JPMorgan Hedged Equity R5
Price$33.64
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets21.1B
Longboard A
Price$14.48
Change-$0.03 (-0.21%)
VolumeN/A
Net Assets137.81M
JHQPX vs LONAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JHQPX vs. LONAX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHQPX is a Buy and LONAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JHQPX has more cash in the bank: 21.1B vs. LONAX (138M). JHQPX pays higher dividends than LONAX: JHQPX (0.86) vs LONAX (0.00). JHQPX was incepted earlier than LONAX: JHQPX (12 years) vs LONAX (10 years). LONAX (2.24) is less costly to investors than JHQPX (0.43). LONAX is a more actively managed with annual turnover of: 102.00 vs. JHQPX (37.00). JHQPX has a lower initial minimum investment than LONAX: JHQPX (0) vs LONAX (2500). JHQPX annual gain was more profitable for investors over the last year : 11.68 vs. LONAX (6.93). JHQPX return over 5 years is better than : 54.32 vs. LONAX (26.05).
JHQPXLONAXJHQPX / LONAX
Total Expense Ratio0.432.2419%
Annual Report Gross Expense Ratio0.432.2419%
Fund Existence12 years10 years-
Gain YTD1.755-1.494-117%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets21.1B138M15,290%
Annual Yield % from dividends0.860.00-
Returns for 1 year11.686.93169%
Returns for 3 years35.7016.23220%
Returns for 5 years54.3226.05209%
Returns for 10 years120.50N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEGNX25.64N/A
N/A
Invesco Discovery Mid Cap Growth R
LMOPX36.39N/A
N/A
Patient Opportunity C
FOVCX21.17N/A
N/A
First Trust/Confluence Small Cap Val C
PPYPX8.84N/A
N/A
PIMCO RAE International I-2
TCGLX59.13N/A
N/A
Touchstone Large Company Growth C